RHIANON IASSOGNA-ROMAN: Open Payments
NPI 1457422057 · DERBY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 17 payments from 8 companies in 2025. Trend: 2023 $527 · 2024 $437 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $162 |
| TOLMAR, INC. | 3 | $81 |
| UROGEN PHARMA, INC. | 2 | $66 |
| Astellas Pharma US Inc | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Boston Scientific Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: ORGOVYX, GEMTESA, JELMYTO, JATENZO, Xtandi, Nubeqa, ELIGARD, SpaceOAR System.
Industry payments across CT — which companies pay providers there.
